Philips and Paige team up to bring AI to clinical pathology diagnostics

Philips and Paige have announced a strategic collaboration to deliver clinical-grade artificial intelligence (AI) applications to pathology laboratories. These AI technologies, starting with Paige Prostate, aim to help pathologists identify, quantify and characterise cancer in tissue samples and make precise diagnoses more efficiently. This may, ultimately, positively impact pathologist’s workflow and treatment planning for [...]

2019-12-09T13:22:50+00:00December 9th, 2019|Tags: , , , , , |

FDA approval for two low-dose paclitaxel-coated balloons for peripheral arterial disease

Stellarex 0.035 Philips has added two new balloons to its portfolio of Stellarex 0.035 low-dose drug-coated balloons, following approval from the FDA. The new 200mm and 150mm Stellarex 0.035 low-dose balloons are now approved and available, in the USA, for the treatment of de novo and restenotic lesions in native superficial femoral [...]

2019-10-21T14:17:07+00:00October 21st, 2019|Tags: , , |
Go to Top